Comparative Efficacy and Safety of Antifungal Agents in the Prophylaxis of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis

Comparative Efficacy and Safety of Antifungal Agents in the Prophylaxis of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis

The objective of the study was to compare the efficacy and safety of antifungal agents used in the prevention of oropharyngeal candidiasis among HIV-infected adults. A systematic search was conducted in four databases (MEDLINE, Scopus, CENTRAL, and Embase) for eligible randomized control trials (RCT...

Full description

Bibliographic Details
Main Authors:	Shamala Gopal Rajadurai, Mari Kannan Maharajan, Sajesh K. Veettil, Divya Gopinath
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Life
Subjects:	oropharyngeal candidiasis oral candidiasis HIV antifungal agents prevention prophylaxis
Online Access:	https://www.mdpi.com/2075-1729/12/4/515

Similar Items

Comparative Efficacy of Antifungal Agents Used in the Treatment of Oropharyngeal Candidiasis among HIV-Infected Adults: A Systematic Review and Network Meta-Analysis
by: Shamala Gopal Rajadurai, et al.
Published: (2021-08-01)

Oropharyngeal candidiasis and resistance to antifungal drugs in patients receiving radiation for head and neck cancer
by: Maryam Rad, et al.
Published: (2012-07-01)

Oropharyngeal candidiasis and resistance to antifungal drugs in patients receiving radiation for head and neck cancer
by: Maryam Rad DMD, MSc, et al.
Published: (2012-04-01)

Ellagic acid: an alternative for antifungal drugs resistance in HIV/AIDS patients with oropharyngeal candidiasis
by: Satutya Wicaksono, et al.
Published: (2020-10-01)

Riboflavin Targets the Cellular Metabolic and Ribosomal Pathways of Candida albicans In Vitro and Exhibits Efficacy against Oropharyngeal Candidiasis
by: Junwen Lei, et al.
Published: (2023-02-01)

Prophylaxis of Antifungal Drugs against Systemic Fungemia induced by Oral Candidiasis in Mice
by: Kazunori Ninomiya, et al.
Published: (2023-02-01)

Oropharyngeal Candidiasis among Egyptian COVID-19 Patients: Clinical Characteristics, Species Identification, and Antifungal Susceptibility, with Disease Severity and Fungal Coinfection Prediction Models
by: Mahmoud A. F. Khalil, et al.
Published: (2022-07-01)

Systematic Genetic Interaction Analysis Identifies a Transcription Factor Circuit Required for Oropharyngeal Candidiasis
by: Norma V. Solis, et al.
Published: (2022-02-01)

High iron-mediated increased oral fungal burden, oral-to-gut transmission, and changes to pathogenicity of Candida albicans in oropharyngeal candidiasis
by: Aparna Tripathi, et al.
Published: (2022-12-01)

Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
by: Elena Roselletti, et al.
Published: (2019-07-01)

Candida isolates causing refractory or recurrent oropharyngeal candidiasis in 11 hospitals in China
by: Yu SY, et al.
Published: (2019-04-01)

Miconazole Nitrate Microparticles in Lidocaine Loaded Films as a Treatment for Oropharyngeal Candidiasis
by: Guillermo Tejada, et al.
Published: (2023-05-01)

Ethnobotanical study of medicinal plants utilized in the management of candidiasis in Northern Uganda
by: Betty Akwongo, et al.
Published: (2022-10-01)

Candidiasis hepatoesplénica en un paciente con leucemia mieloide aguda Hepatosplenic candidiasis in acute myeloid leukemia
by: A. Larregina, et al.
Published: (2004-03-01)

Molecular Typing of Candida Albicans Isolates Recovered from Human Immunodeficiency Virus (HIV)-Infected Patients with Oropharyngeal Candidiasis
by: Farzad Katiraee, et al.
Published: (2014-03-01)

Prevalence and antifungal susceptibility of gastrointestinal candidiasis among diabetic patients: A cross-sectional study
by: Anthony P. Oyom, et al.
Published: (2020-12-01)

Clotrimazole-Loaded Borneol-Based In Situ Forming Gel as Oral Sprays for Oropharyngeal Candidiasis Therapy
by: Nutdanai Lertsuphotvanit, et al.
Published: (2023-05-01)

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
by: Yu Shi, et al.
Published: (2020-04-01)

Features of the Course of the Upper Gastrointestinal Tract Pathology in Patients with Oropharyngeal Candidiasis
by: I.V. Kushnirenko
Published: (2016-04-01)

Therapeutic Response and Antifungal Susceptibility to Fluconazole in Women with Vulvovaginal Candidiasis
by: Zahra Vahedpoor, et al.
Published: (2022-04-01)

Surgical management of chronic hyperplastic candidiasis refractory to systemic antifungal treatment
by: Neha Shah, et al.
Published: (2017-04-01)

Molecular identification and antifungal susceptibility pattern of Candida species isolated form HIV infected patients with candidiasis
by: Sony Paul, et al.
Published: (2019-03-01)

Specific protease mutation patterns are associated with oropharyngeal candidiasis in a New Orleans patient cohort of HIV-infected individuals
by: Peter J. Hickman, et al.
Published: (2015-11-01)

Pediatric Invasive Candidiasis: Epidemiology and Diagnosis in Children
by: William J. Steinbach
Published: (2016-01-01)

Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
by: Angel León-Buitimea, et al.
Published: (2021-10-01)

Phenotypic Characterization and Antifungal Susceptibility Pattern to Fluconazole in Candida species Isolated from Vulvovaginal Candidiasis in a Tertiary Care Hospital
by: Latha Ragunathan, et al.
Published: (2014-05-01)

Vulvovaginal Candidiasis in Pregnancy—Between Sensitivity and Resistance to Antimycotics
by: Nicoleta-Maricica Maftei, et al.
Published: (2023-07-01)

ORAL CANDIDIASIS AND CURRENT TRENDS IN ITS RATIONAL PHARMACOTHERAPY
by: Devіatkina N. M., et al.
Published: (2022-03-01)

Effect of Perillaldehyde on Prophylaxis and Treatment of Vaginal Candidiasis in a Murine Model
by: Su Qu, et al.
Published: (2019-07-01)

Effectiveness and Safety of Micafungin in Managing Invasive Fungal Infections among Patients in Greece with Hematologic Disorders: The ASPIRE Study
by: Maria Kotsopoulou, et al.
Published: (2019-02-01)

Radiation Exposure Perturbs IL-17RA-Mediated Immunity Leading to Changes in Neutrophil Responses That Increase Susceptibility to Oropharyngeal Candidiasis
by: Jessica Saul-McBeth, et al.
Published: (2022-05-01)

Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients
by: Flávio Queiroz-Telles, et al.

Evaluation of efficacy and safety of itraconazole oral solution for the treatment of oropharyngeal candidiasis in AIDS patients
by: Queiroz-Telles Flávio, et al.
Published: (2001-01-01)

Speciation and antifungal susceptibility of esophageal candidiasis in cancer patients in a tertiary care hospital in South India
by: J. Abirami Lakshmy, et al.
Published: (2016-01-01)

Changing Epidemiology of Invasive Candidiasis in Children during a 10-Year Period
by: Maria Noni, et al.
Published: (2019-02-01)

Efficacy of Fluconazole Prophylaxis on Invasive Candidiasis Infection in Extremely Low Birth Weight Neonates
by: Hosein Dalili, et al.
Published: (2020-01-01)

INCIDENCE AND PROGNOSTIC VALUE OF ORAL CANDIDIASIS IN HIV INFECTION
by: Cristina POPA, et al.
Published: (2013-01-01)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
by: Adane Bitew, et al.
Published: (2018-06-01)

Antifungal treatment with carvacrol and eugenol of oral candidiasis in immunosuppressed rats
by: N. Chami, et al.

Biomarker-guided antifungal stewardship policies for patients with invasive candidiasis
by: Behnam Honarvar, et al.
Published: (2018-12-01)